News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,709 Results
Type
Article (42212)
Company Profile (260)
Press Release (676225)
Multimedia
Podcasts (91)
Webinars (16)
Section
Business (206424)
Career Advice (2095)
Deals (35754)
Drug Delivery (100)
Drug Development (82006)
Employer Resources (172)
FDA (16558)
Job Trends (15041)
News (349285)
Policy (33064)
Tag
Academia (2640)
Accelerated approval (15)
Adcomms (28)
Allergies (108)
Alliances (50190)
ALS (129)
Alzheimer's disease (1526)
Antibody-drug conjugate (ADC) (175)
Approvals (16605)
Artificial intelligence (369)
Autoimmune disease (40)
Automation (23)
Bankruptcy (362)
Best Places to Work (11737)
BIOSECURE Act (19)
Biosimilars (137)
Biotechnology (179)
Bladder cancer (112)
Brain cancer (43)
Breast cancer (420)
Cancer (3367)
Cardiovascular disease (272)
Career advice (1754)
Career pathing (32)
CAR-T (209)
CDC (39)
Cell therapy (560)
Cervical cancer (27)
Clinical research (68019)
Collaboration (1192)
Company closure (4)
Compensation (846)
Complete response letters (38)
COVID-19 (2695)
CRISPR (70)
C-suite (478)
Cystic fibrosis (123)
Data (3765)
Decentralized trials (2)
Denatured (44)
Depression (83)
Diabetes (393)
Diagnostics (6564)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (169)
Drug pricing (139)
Drug shortages (29)
Duchenne muscular dystrophy (174)
Earnings (89163)
Editorial (47)
Employer branding (21)
Employer resources (148)
Events (116014)
Executive appointments (900)
FDA (18737)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1056)
Gene editing (151)
Generative AI (25)
Gene therapy (450)
GLP-1 (848)
Government (4631)
Grass and pollen (5)
Guidances (331)
Healthcare (19232)
HIV (42)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (188)
Immuno-oncology (15)
Indications (46)
Infectious disease (2888)
Inflammatory bowel disease (167)
Inflation Reduction Act (10)
Influenza (77)
Intellectual property (164)
Interviews (339)
IPO (16722)
IRA (48)
Job creations (3675)
Job search strategy (1476)
Kidney cancer (13)
Labor market (64)
Layoffs (529)
Leadership (22)
Legal (8027)
Liver cancer (87)
Longevity (11)
Lung cancer (485)
Lymphoma (244)
Machine learning (22)
Management (58)
Manufacturing (516)
MASH (111)
Medical device (13887)
Medtech (13904)
Mergers & acquisitions (19841)
Metabolic disorders (959)
Multiple sclerosis (114)
NASH (17)
Neurodegenerative disease (158)
Neuropsychiatric disorders (37)
Neuroscience (2358)
NextGen: Class of 2025 (6619)
Non-profit (4568)
Now hiring (53)
Obesity (466)
Opinion (238)
Ovarian cancer (111)
Pain (147)
Pancreatic cancer (145)
Parkinson's disease (203)
Partnered (24)
Patents (370)
Patient recruitment (262)
Peanut (52)
People (58565)
Pharmaceutical (63)
Pharmacy benefit managers (23)
Phase I (21202)
Phase II (29965)
Phase III (22285)
Pipeline (2418)
Policy (237)
Postmarket research (2580)
Preclinical (9096)
Press Release (65)
Prostate cancer (165)
Psychedelics (41)
Radiopharmaceuticals (259)
Rare diseases (541)
Real estate (5991)
Recruiting (66)
Regulatory (23441)
Reports (51)
Research institute (2392)
Resumes & cover letters (356)
Rett syndrome (11)
RNA editing (15)
RSV (55)
Schizophrenia (108)
Series A (174)
Series B (133)
Service/supplier (11)
Sickle cell disease (71)
Special edition (21)
Spinal muscular atrophy (151)
Sponsored (34)
Startups (3656)
State (2)
Stomach cancer (15)
Supply chain (89)
Tariffs (72)
The Weekly (45)
Vaccines (886)
Venture capital (59)
Weight loss (294)
Women's health (53)
Worklife (18)
Date
Today (4)
Last 7 days (491)
Last 30 days (2154)
Last 365 days (31110)
2025 (22042)
2024 (35579)
2023 (40484)
2022 (51663)
2021 (56154)
2020 (54550)
2019 (47125)
2018 (35538)
2017 (32590)
2016 (31974)
2015 (38011)
2014 (31707)
2013 (26777)
2012 (28996)
2011 (29664)
2010 (27698)
Location
Africa (741)
Alabama (70)
Alaska (7)
Arizona (263)
Arkansas (13)
Asia (39239)
Australia (6400)
California (8622)
Canada (2671)
China (791)
Colorado (361)
Connecticut (369)
Delaware (227)
Europe (84662)
Florida (1280)
Georgia (291)
Hawaii (2)
Idaho (60)
Illinois (687)
India (42)
Indiana (410)
Iowa (17)
Japan (261)
Kansas (117)
Kentucky (31)
Louisiana (16)
Maine (65)
Maryland (1142)
Massachusetts (6313)
Michigan (267)
Minnesota (510)
Mississippi (4)
Missouri (109)
Montana (28)
Nebraska (25)
Nevada (99)
New Hampshire (72)
New Jersey (2367)
New Mexico (29)
New York (2338)
North Carolina (1212)
North Dakota (8)
Northern California (3921)
Ohio (262)
Oklahoma (17)
Oregon (36)
Pennsylvania (1819)
Puerto Rico (17)
Rhode Island (42)
South America (1120)
South Carolina (44)
South Dakota (1)
Southern California (3303)
Tennessee (138)
Texas (1326)
United States (31419)
Utah (257)
Virginia (212)
Washington D.C. (75)
Washington State (717)
West Virginia (4)
Wisconsin (72)
718,709 Results for "sri surgical express inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Synfini, Inc. Spins Out of SRI International to Bring Novel Molecular Discovery Platform to Market
Synfini, Inc. announced that it has acquired rights to the patented Synfini® platform from SRI International®, and that it will operate as an independent firm.
September 26, 2023
·
4 min read
Press Releases
QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)
June 16, 2025
·
9 min read
Press Releases
Protein Expression Technology Market Strengthens USD 5.58 Billion by 2034
July 25, 2025
·
1 min read
Press Releases
Angle PLC - EACR 2025: Innovation in AR Expression Profiling
June 17, 2025
·
5 min read
Press Releases
Junshi Biosciences Announces the Acceptance of the sNDA for Toripalimab as the 1st-line Treatment of HER2-expressing Urothelial Carcinoma
August 11, 2025
·
6 min read
Press Releases
Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab
September 15, 2025
·
13 min read
Press Releases
Alcon Agrees to Acquire STAAR Surgical
August 5, 2025
·
12 min read
Press Releases
ALX Oncology Doses First Patient in Phase 1 Dose Escalation Trial Evaluating ADC ALX2004 for the Treatment of EGFR-Expressing Solid Tumors
August 20, 2025
·
5 min read
Press Releases
PDS Biotech Sets Significant Benchmark in Head and Neck Cancer by Achieving Extended Survival in Low PD-L1 Expression (CPS 1–19) Cohort in VERSATILE-002 Trial, Potentially Eliminating Need for Chemotherapy in the Population
September 18, 2025
·
7 min read
N4 Pharma announces collaboration with SRI to target and treat cells in the human body that have been previously unreachable
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system designed to carry nucleotides to be developed as cancer treatments and vaccines, has entered into a research collaboration agreement with SRI, an independent nonprofit research institute based in Silicon Valley, California
April 26, 2024
·
4 min read
1 of 71,871
Next
